TRPC6 and endothelial dysfunction: Therefore, we next tested whether larixyl-mediated inhibition of TRPC6 activity in vivo would be efficacious at reducing TBI-associated endothelial dysfunction in 129S-C57BL/6-F2 and C57BL/6 mice subjected to TBI and treated with larixyl acetate.